Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04433351 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sensory-Motor Integration for Speech Rehabilitation in Patients With Post-stroke Aphasia

Study acronym: SEMO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 1 month later Mar 2026 → May 5, 2028
See other at-risk trials from University Hospital, Grenoble

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Mar 2026 to May 5, 2028
    • Enrollment increased: 36 → 80 participants
    • Secondary endpoints: details revised at 8 of 22 entries
    • Eligibility criteria expanded, about 5 words
  2. Primary and study completion dates: May 2026 to Mar 2026
    • Eligibility criteria shortened, about 8 words
    • Secondary endpoints: details revised at 1 of 22 entries
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary and study completion dates: Jul 2025 to May 2026
    • Start date: Jan 15, 2021 to May 5, 2022
    • Secondary endpoints: details revised at 2 of 22 entries
    v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Sep 1, 2021 to Jul 2025
    • Study sites: 0 to 1
    • Study completion date: Sep 1, 2022 to Jul 2025
    • Start date changed from estimate of Jan 1, 2021 to Jan 15, 2021
  2. Start date: Sep 1, 2020 to Jan 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
SEMO is a multidisciplinary project (language sciences, cognitive psychology and neuropsychology, physical medicine and rehabilitation, neurology, speech-language pathology, functional neuroimaging and engineering sciences) that aims first, to test and develop a novel speech rehabilitation program designed for patients with non-fluent aphasia and, second, to better describe neural reorganization after successful recovery. To this end, the investigators will conduct a prospective monocentric cross-over study, including two cohorts of post-stroke aphasic patients and two control groups.
Trial Details
NCT Number NCT04433351
Lead Sponsor University Hospital, Grenoble
Collaborators: Laboratoire de Psychologie et NeuroCognition, GIPSA-LAB
Conditions
(from sponsor)		 Aphasia Non Fluent, Stroke
Related terms Aphasia, Broca, Stroke
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov